Adagio Medical Inc.
ADGM | NASDAQ
$0.49
-$0.01 (-2.58%)
Sep 22, 2026, 10:46 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | 269K | 300K | 189K | 270K | n/a |
Cost of Revenue | 684K | 1.94M | 1.31M | 875K | 1.16M | n/a |
Gross Profit | -684K | -1.67M | -1.01M | -686K | -888K | n/a |
Operating Income | -21.89M | -62.48M | -27.94M | -23.91M | -20.65M | -13.54K |
Interest Income | 477K | 423K | 3K | 39K | 3K | n/a |
Pretax Income | -25.08M | -53.76M | -38.15M | -23.67M | -19.94M | -13.54K |
Net Income | -25.08M | -53.76M | -38.15M | -23.67M | -19.94M | -13.54K |
Selling & General & Admin | 10.57M | 6.98M | 11.54M | 5.37M | 4.4M | 13.54K |
Research & Development | 10.64M | 4.63M | 15.4M | 17.86M | 15.36M | n/a |
Other Expenses | n/a | 49.2M | n/a | n/a | n/a | n/a |
Operating Expenses | 21.21M | 60.81M | 26.94M | 23.23M | 19.76M | 13.54K |
Interest Expense | 2.91M | -1.1M | 1.66M | 137K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 6.78M | n/a | n/a | n/a |
Cost & Expenses | 21.89M | 62.75M | 28.24M | 24.1M | 20.92M | 13.54K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 16.58M | 15.2M | 13.39M | 19.19M | 19.19M | 19.19M |
Shares Outstanding (Diluted) | 16.58M | 15.2M | 13.39M | 19.19M | 19.19M | 19.19M |
EPS (Basic) | -1.51 | -3.54 | -0.16 | -1.23 | -0.34 | 0 |
EPS (Diluted) | -1.51 | -3.54 | -0.16 | -1.23 | -0.34 | 0 |
EBITDA | -21.21M | -53.48M | -35.96M | -23.04M | -19.6M | -13.54K |
EBIT | -22.18M | -54.87M | -36.49M | -23.54M | -19.94M | -13.54K |
Depreciation & Amortization | 970K | 1.39M | 532K | 495K | 336K | n/a |
Add to Watchlist
Select watchlists to add or remove ADGM